Soluble Toll-like receptor 4 is a potential serum biomarker in non-small cell lung cancer

This study investigated the clinical significance of serum soluble Toll-like receptor 4 (sTLR4) in non-small cell lung cancer (NSCLC). A total of 54 NSCLC patients and 13 healthy volunteers were enrolled from January 2012 to December 2013. The patients with NSCLC were characterized by significantly...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Feng, Yang, Fan, Li, Jing, Zheng, Yu, Yu, Wenwen, Yang, Lili, Ren, Xiubao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129996/
https://www.ncbi.nlm.nih.gov/pubmed/27223258
http://dx.doi.org/10.18632/oncotarget.9496

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129996/
https://www.ncbi.nlm.nih.gov/pubmed/27223258
http://dx.doi.org/10.18632/oncotarget.9496

Ejemplares similares